Invivyd Statistics
NASDAQ: IVVDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.7007-0.0279 (-3.83%)
Market open · Delayed 15 min · as of Oct 8, 12:18 PM ET
Invivyd by the numbers
Invivyd has a market capitalization of $206.5 million based on 294.76M shares outstanding. With trailing EPS of $-0.33, Invivyd is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.3% below its 50-day average and 47.2% below its 200-day average.
Average daily trading volume is 4.78M shares, or about $3.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IVVD valuation vs. peer median
| Metric | IVVD | Peer median | Difference |
|---|---|---|---|
| Market cap | $206.54M | $225.70M | -8% |
| Avg. volume | 4.78M | 1.52M | +215% |
Peer median across 8 companies: PLX, ALEC, IPSC, CGEN, PALI, FATE, LCTX, CMPX.
Valuation
- Market cap
- $206.54M
- EPS (TTM)
- $-0.33
- Shares outstanding
- 294.76M
Price and trading
- Previous close
- 0.7286
- Open
- 0.7398
- Day range
- 0.67 – 0.74
- 52-week range
- 0.528 – 3.07
- 52-week change
- -55.30%
- 50-day moving average
- 0.8081
- Beta
- —
- Volume
- 3.38M
- Average volume
- 4.78M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 206.54M
- Forward Pe
- -1.27
- Eps
- -0.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.07
- Week52 Low
- 0.53
- Avg Volume
- 4.78M
- Shares Outstanding
- 294.76M
- Ma50
- 0.81
- Ma200
- 1.33
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -77.18%
- Pct From52w Low
- 32.71%